Akeso racks up Series D
Drug developer Akeso has raised nearly $150 million in Series D financing. Loyal Valley Capital and Sino Biopharmaceutical Co. Ltd led the round.
8 November 2019•1 min read
Drug developer Akeso has raised nearly $150 million in Series D financing. Loyal Valley Capital and Sino Biopharmaceutical Co. Ltd led the round.
May River Capital agrees to $675m sale of Parameter Technologies to Acuity
2 hours ago · 1 min read
Onyx Partners strikes two-phase deal for Florida retailer Kane’s Furniture
3 hours ago · 1 min read
Kester-backed Evestia Clinical acquires Belgian medical writing firm Emtex in third add-on
3 hours ago · 1 min read
Weatherford Capital invests in Arnold Palmer Junior Golf Tour alongside Bolt Ventures
3 hours ago · 2 mins read
Permira agrees to buy Flint Group majority stake from General Atlantic
4 hours ago · 2 mins read
Transom strikes deal to carve out Cree LED from Penguin Solutions
4 hours ago · 2 mins read
Levine Leichtman makes growth investment in utility adviser Concentric Energy Advisors
4 hours ago · 2 mins read
